NEUROPHET, Inc. (KOSDAQ:380550)

NEUROPHET Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	4,102	3,017
Short-Term Investments	19,667	3,000
Cash & Short-Term Investments	23,768	6,017
Cash Growth	295.00%	-
Accounts Receivable	223.17	353.94
Other Receivables	226.49	96.29
Receivables	449.67	450.23
Inventory	47.24	10.86
Prepaid Expenses	227.65	54.99
Other Current Assets	521.61	354.34
Total Current Assets	25,015	6,888
Property, Plant & Equipment	1,275	1,992
Long-Term Investments	0	-0
Other Intangible Assets	434.33	470.29
Other Long-Term Assets	160.99	510.25
Total Assets	26,884	9,860
Accrued Expenses	455.83	364.47
Short-Term Debt	4,804	3,522
Current Portion of Leases	686	625.07
Other Current Liabilities	991.74	30,963
Total Current Liabilities	6,937	35,474
Long-Term Leases	40.56	665.06
Other Long-Term Liabilities	454.44	616.24
Total Liabilities	7,432	36,755
Common Stock	11,637	3,691
Additional Paid-In Capital	85,611	105.01
Retained Earnings	-78,249	-55,860
Comprehensive Income & Other	453.81	867.16
Total Common Equity	19,452	-51,197
Shareholders' Equity	19,452	-26,895
Total Liabilities & Equity	26,884	9,860
Total Debt	5,530	4,812
Net Cash (Debt)	18,238	1,206
Net Cash Growth	1412.64%	-
Net Cash Per Share	1875.21	326.63
Filing Date Shares Outstanding	9.73	3.69
Total Common Shares Outstanding	9.73	3.69
Working Capital	18,077	-28,586
Book Value Per Share	2000.04	-13869.37
Tangible Book Value	19,018	-51,667
Tangible Book Value Per Share	1955.38	-13996.77
Machinery	1,035	869.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.